http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-015761-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_065fe7c4146d471ac47823ff7c1d911f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-60 |
| filingDate | 1999-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-015761-A1 |
| titleOfInvention | A 2-METHYLPROPIONIC ACID DERIVATIVE, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, USE OF A 2-METHYLPROPIONIC ACID DERIVATIVE AND A PARALLY PROCEDURE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF DISEASES |
| abstract | The 2-methylpropionic acid derivative is represented by the general formula (I), wherein R 1 represents a hydroxy group, a lower alkoxy group or an aralkyl group; R2 represents a hydroxy group, a lower alkyl group or a halogen atom; A represents an oxygen atom or an imino group; the C atom marked with (R) represents a C atom in the R configuration and the C atom marked with (S) represents a C atom in the S configuration; and its pharmaceutically acceptable salts, which have excellent stimulatory effects of beta3-adrenoceptors and are useful as agents for the prevention or treatment of obesity, hyperglycemia, diseases caused by intestinal hypermotility, polaquuria, urinary incontinence, depression or diseases caused by gallstones or hypermotility of the biliary tract. Pharmaceutical composition and agent that includes said derivative as active component. A process for the manufacture of a pharmaceutical composition using said derivative as an essential constituent. |
| priorityDate | 1998-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.